BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11070477)

  • 1. White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.
    Pääkkö E; Harila-Saari A; Vanionpää L; Himanen S; Pyhtinen J; Lanning M
    Med Pediatr Oncol; 2000 Nov; 35(5):456-61. PubMed ID: 11070477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.
    Lo Nigro L; Di Cataldo A; Schiliro G
    Med Pediatr Oncol; 2000 Nov; 35(5):449-55. PubMed ID: 11070476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain perfusion after treatment of childhood acute lymphoblastic leukemia.
    Harila-Saari AH; Ahonen AK; Vainionpää LK; Pääkkö EL; Pyhtinen J; Himanen AS; Torniainen PJ; Lanning BM
    J Nucl Med; 1997 Jan; 38(1):82-8. PubMed ID: 8998157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate.
    Asato R; Akiyama Y; Ito M; Kubota M; Okumura R; Miki Y; Konishi J; Mikawa H
    Cancer; 1992 Oct; 70(7):1997-2004. PubMed ID: 1525778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
    Zając-Spychała O; Pawlak MA; Karmelita-Katulska K; Pilarczyk J; Derwich K; Wachowiak J
    Neuroradiology; 2017 Feb; 59(2):147-156. PubMed ID: 28074235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter changes in children treated for acute lymphoblastic leukemia.
    Pääkkö E; Vainionpää L; Lanning M; Laitinen J; Pyhtinen J
    Cancer; 1992 Dec; 70(11):2728-33. PubMed ID: 1423204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
    Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
    Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing changes in microstructural integrity of white matter tracts in children with leukaemia following exposure to chemotherapy.
    Ramli N; Lim CH; Rajagopal R; Tan LK; Seow P; Ariffin H
    Pediatr Radiol; 2020 Aug; 50(9):1277-1283. PubMed ID: 32591982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model.
    Lesnik PG; Ciesielski KT; Hart BL; Benzel EC; Sanders JA
    Arch Neurol; 1998 Dec; 55(12):1561-8. PubMed ID: 9865801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter.
    Laxmi SN; Takahashi S; Matsumoto K; Higano S; Kurihara N; Imaizumi M; Abe K; Itoyama Y; Sakamoto K
    Radiat Med; 1996; 14(6):303-7. PubMed ID: 9132810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits.
    Brouwers P; Poplack D
    Am J Pediatr Hematol Oncol; 1990; 12(2):174-81. PubMed ID: 2116096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
    Seidel H; Nygaard R; Haave I; Moe PJ
    Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.